Search research articles
Contact Us
Filters
Showing results (241-250 of 327) with videos related to
Page
of 33
Sort By:
Klinische Wochenschrift
|
February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum
D Fritze, B Massner, R Becher, et al.
Leukemia & Lymphoma
|
January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1
R Hehlmann, H Heimpel, H J Kolb, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]
A C Mayr, H J Senn, W M Gallmeier, et al.
Plos One
|
June 9, 2016
Flow Cytometric Quantification of Peripheral Blood Cell β-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension
Jonathan A Rose, Nicholas Wanner, Hoi I Cheong, et al.
Journal of Cell Science
|
August 23, 2017
Conserved cytoplasmic domains promote Hrd1 ubiquitin ligase complex formation for ER-associated degradation (ERAD)
Jasmin Schulz, Dönem Avci, Markus A Queisser, et al.
Onkologie
|
November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
G Hartung, R D Hofheinz, A Wein, et al.
British Journal of Haematology
|
April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group
R Hehlmann, H Ansari, J Hasford, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 27, 2016
Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response
Kewal Asosingh, Amit Vasanji, Aaron Tipton, et al.
International Journal of Molecular Sciences
|
December 28, 2016
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
Anne von Mässenhausen, Johannes Brägelmann, Hannah Billig, et al.
Page
of 33
Search research articles
Search
Showing results (241-250 of 327) with videos related to
Sort By:
Page
of 33
Klinische Wochenschrift
|
February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvum
D Fritze, B Massner, R Becher, et al.
Leukemia & Lymphoma
|
January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1
R Hehlmann, H Heimpel, H J Kolb, et al.
Onkologie
|
April 1, 1987
5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)"
H Flechtner, W Queisser, M E Heim, et al.
Deutsche Medizinische Wochenschrift (1946)
|
December 7, 1979
[Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)]
A C Mayr, H J Senn, W M Gallmeier, et al.
Plos One
|
June 9, 2016
Flow Cytometric Quantification of Peripheral Blood Cell β-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension
Jonathan A Rose, Nicholas Wanner, Hoi I Cheong, et al.
Journal of Cell Science
|
August 23, 2017
Conserved cytoplasmic domains promote Hrd1 ubiquitin ligase complex formation for ER-associated degradation (ERAD)
Jasmin Schulz, Dönem Avci, Markus A Queisser, et al.
Onkologie
|
November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer
G Hartung, R D Hofheinz, A Wein, et al.
British Journal of Haematology
|
April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group
R Hehlmann, H Ansari, J Hasford, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 27, 2016
Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response
Kewal Asosingh, Amit Vasanji, Aaron Tipton, et al.
International Journal of Molecular Sciences
|
December 28, 2016
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression
Anne von Mässenhausen, Johannes Brägelmann, Hannah Billig, et al.
Page
of 33